… We assess the progress and current challenges of cancer drug discovery, and finally we …
of cancer therapeutics. The molecular basis of cancer: drugging the cancer genome …

… medicines are potential toxicity … cancer therapeutics. This review highlights
nanopharmaceuticals that have been investigated in oncology for various applications (diagnosis, …

… characteristics of the cancer that provide opportunities for drug delivery carriers to target cancer.
These … The newer approaches to cancer treatment not only supplement the conventional …

… study indicate that cyclic depsipeptides could be a rich source of new cancer therapeutics. …
human esophageal squamous cancer cell lines showed that the drug upregulated 11 genes …

… The mTOR axis is often activated in many types of cancer and thus has become an attractive
cancer therapeutic target. The modest clinical anticancer activity of conventional mTOR …

… of cancer therapeutics is the targeting of drugs to the tumor by using the specificity of antibodies.
All different kinds of drug … In addition to being effective cancer therapeutics on their own, …

… , we present our current understanding of the targeted therapeutic potential of transcription
factors and the role of CGs in modulating these proteins in cancer as depicted in Figure 2. …

… of novel cancer treatment strategies. In contrast to conventional cancer therapeutics, novel
… release, intracellular drug targeting, gene delivery, cancer stem cell therapy, magnetic …

… single drug treatment module due to higher internalization of chemotherapeutics in the cancer
… The cancer therapeutics involves different methodologies of delivering active moiety to the …

… In fact, this strategy of using existing therapeutics for new indications has demonstrated … III
clinical trials as a cancer therapeutic (1). Ideal candidates for drug repurposing are entities that …